Big Pharma Strategies for Biologics Catch-Up

By Business Review Editor

Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)

Published: 1 Jan-2008

DOI: 10.3833/pdr.v2008.i91.235     ISSN: 1756-7874

Section: Features



The healthcare industry is based on a history of small molecule therapeutics, but, today, the industry#8217;s potential is considered by many to lie in biologics, although the majority of therapeutic drug sales are still for small molecules...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details